Cas no 909545-47-7 (4-fluoro-2-iodobenzaldehyde)
4-fluoro-2-iodobenzaldehyde Chemical and Physical Properties
Names and Identifiers
-
- Benzaldehyde, 4-fluoro-2-iodo-
- 4-Fluoro-2-iodobenzaldehyde
- DTXSID40733744
- 909545-47-7
- 4-Fluoro-2-iodo-benzaldehyde
- EN300-254251
- AS-46374
- DB-078845
- AKOS027339601
- SCHEMBL24014740
- Z1269211883
- MFCD12025051
- CL9496
- DTXCID80684488
- 4-fluoro-2-iodobenzaldehyde
-
- MDL: MFCD12025051
- Inchi: 1S/C7H4FIO/c8-6-2-1-5(4-10)7(9)3-6/h1-4H
- InChI Key: YPHYBDRMBQLXSS-UHFFFAOYSA-N
- SMILES: IC1C=C(C=CC=1C=O)F
Computed Properties
- Exact Mass: 249.92909g/mol
- Monoisotopic Mass: 249.92909g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 10
- Rotatable Bond Count: 1
- Complexity: 129
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.1
- Topological Polar Surface Area: 17.1?2
4-fluoro-2-iodobenzaldehyde Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | F632763-50mg |
4-Fluoro-2-Iodobenzaldehyde |
909545-47-7 | 50mg |
$ 50.00 | 2022-06-04 | ||
| TRC | F632763-100mg |
4-Fluoro-2-Iodobenzaldehyde |
909545-47-7 | 100mg |
$ 70.00 | 2022-06-04 | ||
| TRC | F632763-500mg |
4-Fluoro-2-Iodobenzaldehyde |
909545-47-7 | 500mg |
$ 230.00 | 2022-06-04 | ||
| abcr | AB457876-1 g |
4-Fluoro-2-iodobenzaldehyde, 95%; . |
909545-47-7 | 95% | 1g |
€284.50 | 2023-07-18 | |
| abcr | AB457876-5 g |
4-Fluoro-2-iodobenzaldehyde, 95%; . |
909545-47-7 | 95% | 5g |
€746.20 | 2023-07-18 | |
| Alichem | A014000878-250mg |
4-Fluoro-2-iodobenzaldehyde |
909545-47-7 | 97% | 250mg |
$494.40 | 2023-08-31 | |
| Alichem | A014000878-500mg |
4-Fluoro-2-iodobenzaldehyde |
909545-47-7 | 97% | 500mg |
$863.90 | 2023-08-31 | |
| Alichem | A014000878-1g |
4-Fluoro-2-iodobenzaldehyde |
909545-47-7 | 97% | 1g |
$1490.00 | 2023-08-31 | |
| Enamine | EN300-254251-1g |
4-fluoro-2-iodobenzaldehyde |
909545-47-7 | 95% | 1g |
$342.0 | 2023-09-14 | |
| Enamine | EN300-254251-5g |
4-fluoro-2-iodobenzaldehyde |
909545-47-7 | 95% | 5g |
$991.0 | 2023-09-14 |
4-fluoro-2-iodobenzaldehyde Related Literature
-
Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
-
2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
-
Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
Additional information on 4-fluoro-2-iodobenzaldehyde
Recent Advances in the Application of 4-Fluoro-2-Iodobenzaldehyde (CAS: 909545-47-7) in Chemical Biology and Pharmaceutical Research
4-Fluoro-2-iodobenzaldehyde (CAS: 909545-47-7) has emerged as a versatile building block in chemical biology and pharmaceutical research due to its unique reactivity and structural properties. Recent studies have highlighted its potential in the synthesis of bioactive molecules, particularly in the development of targeted therapies and diagnostic agents. This research brief consolidates the latest findings on the applications and mechanistic insights of this compound, providing a comprehensive overview for researchers in the field.
One of the most significant advancements involves the use of 4-fluoro-2-iodobenzaldehyde as a key intermediate in the synthesis of fluorinated aromatic compounds. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in Suzuki-Miyaura cross-coupling reactions, enabling the construction of complex biaryl structures with high selectivity. The presence of both fluorine and iodine substituents on the benzene ring facilitates orthogonal functionalization, making it an attractive scaffold for drug discovery.
In the realm of radiopharmaceuticals, 4-fluoro-2-iodobenzaldehyde has been employed as a precursor for the synthesis of 18F-labeled probes. Researchers at the University of California, San Francisco, recently reported its use in the development of PET tracers for imaging neurodegenerative diseases. The compound's ability to undergo nucleophilic aromatic substitution with 18F-fluoride ions under mild conditions has significantly improved radiolabeling yields, addressing a critical challenge in tracer production.
Beyond its synthetic utility, mechanistic studies have shed light on the compound's interactions with biological targets. Molecular docking simulations revealed that derivatives of 4-fluoro-2-iodobenzaldehyde exhibit strong binding affinity to the allosteric site of kinase enzymes, suggesting potential applications in kinase inhibitor design. This finding was further validated by in vitro assays showing nanomolar inhibition of JAK2 and EGFR kinases, as reported in a 2024 ACS Chemical Biology publication.
The safety profile and metabolic stability of 4-fluoro-2-iodobenzaldehyde derivatives have also been investigated. Recent ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies indicate that fluorination at the 4-position enhances metabolic stability compared to non-fluorinated analogs, while the iodo substituent allows for subsequent functionalization without compromising pharmacokinetic properties. These characteristics position the compound as a promising candidate for lead optimization in medicinal chemistry programs.
Looking ahead, researchers are exploring the use of 4-fluoro-2-iodobenzaldehyde in DNA-encoded library (DEL) technology for high-throughput screening of protein targets. Its compatibility with click chemistry and photochemical reactions enables the construction of diverse compound libraries, as demonstrated in a recent collaboration between academia and industry published in Nature Chemistry. This approach is expected to accelerate the discovery of novel bioactive molecules in the coming years.
909545-47-7 (4-fluoro-2-iodobenzaldehyde) Related Products
- 13194-67-7(4-Fluoro-2-iodotoluene)
- 146137-72-6(2-fluoro-6-iodobenzaldehyde)
- 699016-40-5(2-Fluoro-4-iodobenzaldehyde)
- 1208077-39-7(3,Difluoro-2-iodobenzaldehyde)
- 857444-52-1(Benzoic acid, 4-fluoroiodo-)
- 877264-44-3(5-Fluoro-2-iodobenzaldehyde)
- 56096-89-0(4-Fluoro-2-iodobenzoic acid)
- 887586-24-5(2,3-Difluoro-6-iodobenzaldehyde)
- 914636-93-4(3-Fluoro-5-iodobenzaldehyde)
- 905808-02-8(3-Fluoro-2-iodobenzaldehyde)